US1266501006 - Common Stock
Each of these seven blue-chip stocks to buy on the dip offer high-quality at a more-than-reasonable price.
These stocks all deserve to be trading at far higher prices, and it may not be too long before they start to rally.
/PRNewswire/ -- CVS Health® (NYSE: CVS) today announced it has invested $19.2 million through Boston Financial to build 85 new affordable housing units in...
/PRNewswire/ -- Baum Family Investments (BFI) proudly announces its official debut in the real estate investment landscape. With over fifteen years of...
If you’re looking for reliability, jump into safer blue-chip stocks. They’re not all exciting, but they have proven to be ultra-reliable.
The change in interest rate expectations has created a big opportunity for patient investors.
The change in interest rate expectations has created a big opportunity for patient investors.
These stocks all offer growing and generous dividends.
AbbVie is working against numerous biosimilar versions of Humira. But one has "stepped up dramatically."
Fortify your portfolio against increased market volatility with three defensive stocks that perform no matter what the economic climate.
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Stocks with women CEOs often outperform their counterparts. These three companies are great examples of that.
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
/PRNewswire/ -- Aetna Better Health of Michigan, a CVS Health® company (NYSE: CVS), has been recommended by the Michigan Department of Health and Human...
The indexes and leading stocks are generally holding key levels.
CVS Health Corp. drug plans will cover over-the-counter oral birth control in the US, a step that further removes barriers to obtaining oral contraception as reproductive rights increasingly come under fire.
/PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced...
The federal agency that administers the Medicare program just approved a 3.7% payment rate increase. Here's why that's bad for insurance stocks.
Investors are growing gloomy about the chances the Fed will delay a rate cut until the second half of the year.
Final Medicare Advantage rates were unchanged vs. the initial proposal.
Uncover strategic moves by three pharma giants poised to capture trends and fulfill emerging healthcare needs.
/PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m. ET to discuss first...
Major health insurers will now cover Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy for certain Medicare beneficiaries with heart-related conditions.
Discover the untapped potential of disruptive healthcare stocks, capitalizing on transformative healthcare technology and delivery.